Default company panoramic image
Logo

IntelliDex Rx

New standard in drug knowledge support: adv. comp. linguistics, NLP, analytics gives precise, visually-cued drug decision info. & insight.

  • Stage Prototype Ready
  • Industry IT Services
  • Location Arroyo Grande, CA, USA
  • Currency USD
  • Founded November 2011
  • Employees 9
  • Website intellidex.biz

Company Summary

Product supports drug related decisions by assisting clinical professionals to discover, synthesize & understand latest drug info & research at 50 pgs/sec in 9 languages. Benefits: 10-30% cost saving, improve quality & safety of patient care outcomes, reduce litigation costs, & significantly reduce med errors. Market:16,598 U.S. health care delivery inst., group med practices, insurors, research, educ., life sciences, govt-domestic & global.

Team

  • Default avatar
    Alan E. Cremer, Ed.D.
    CoFounder & EVP Corporate Developmentnt

    Alan brings more than 25 years experience in Organizational Development & HR mgt in IT healthcare start-ups & early stage companies to IntelliDex Rx. Trained as an Industrial Psychologist Alan was a faculty member a Harvard Medical School for 22 years. Specialties include: OD, HR, restructuring corporations, executive consultation to Boards and Senior Mgt. Education: Babson College, Suffolk University, Boston University, Harvard Medical School.

  • Default avatar
    Rudy F. Xavier, M.S.
    Co-Founder & COO

    Rudy was part of a Fortune 100 Company team that developed the core technology on which IntelliDex Rx is built. Rudy brings specific application design & development experience to the Company based on his technical systems & medical training. Rudy has a unique perspective, transitioning from code development to sales of specialized AI-based software. Experienced at several start-up software companies. Education: Fulbright scholar, Southern IL U.

  • Default avatar
    Alan F. Dowling, Ph.D.
    CEO & President

    Alan is also Adj. Prof. at Case Western University. Areas of expertise: health bus & info strategies, process & product innovation, health IT applications, transfer & adolption, M&A, channel distribution & global health systems. Prior E&Y Partner for Health Care IS & Global Health Care Consulting Practices. Managed pre-angel start-ups through health systems, lg corps & govt. in U.S & internationally. Education: Holy Cross, U of Dayton, & MIT

  • Default avatar
    David A. Butler, MBA
    CFO

    David has been CFO of 2 publically traded companies; Sequoia Systems where he led the financial & administrative groups from pre-revenue state to a multinational, public company with revenues exceeding $100M & Biopure. He also has worked with smaller early stage/growth public and private companies on revenue recognition, valuations, ownership transition planning as a financial consultant. Education: Boston University.

  • Default avatar
    Richard P. Goodkin, Esq.
    Corporate Counsel

    Richard has more than 35 years experience as General Counsel for several major public and private high-tech corps. Legal background includes domestic & international negotiations, IPO leadership, licensing, litigation, contracts, bids and employee issues. Previously cofounder of UniCad which he successfully sold for $10M. Richard is an angel investor in several private medical healthcare start-ups. Education: Princeton and Harvard Law School.

Advisors

  • Default avatar
    Dr. Bruce Canaday Pharm. D.
    Advisory Board - Clinical Pharmacology & Processes Advisor
    Unconfirmed
    D321724a e4fa 471e 8db2 f55c68a5297e
    Clinical Pharmacology & Process Advisor
    Default avatar
    Janet Hofmeister, Pharm D.
    Advisory Board - Clinical Pharmacology & Process Advisor
    Unconfirmed
  • Default avatar
    Neeraj L. Khanna, B.S.E.E. (Honors)
    Advisory Board Technical Advisor
    Unconfirmed
    Default avatar
    Gail M. McFaddin, Ma.P.A.
    Advisory Board - Market Advisor
    Unconfirmed
    Default avatar
    Jim Medeiros, B.S.E.E.
    Advisory Board - Product Management Advisor
    Unconfirmed

Previous Investors

  • Default avatar
    Dr. Besie Hazard MD
    Unconfirmed
    Default avatar
    Michael Loftus
    Unconfirmed
    Default avatar
    Family & Friends
    Unconfirmed